Developing Next-Generation Targeted High-Capacity Drug Conjugates for Higher Drug-to-Antibody Ratio
Time: 12:00 pm
day: Conference Day One - Track 2 - AM
Details:
- Delivering more payload beyond traditional ADCs and other high DAR platforms
- Advancing the platform of high-DAR pipeline products with a broad therapeutic index
- Platform flexibility to efficiently mix-and-match payloads and targets for fast product development
